Literature DB >> 18480554

A simple method to induce differentiation of murine bone marrow mesenchymal cells to insulin-producing cells using conophylline and betacellulin-delta4.

Etsuko Hisanaga1, Kee-Yong Park, Satoko Yamada, Hiromi Hashimoto, Toshiyuki Takeuchi, Masatomo Mori, Masaharu Seno, Kazuo Umezawa, Izumi Takei, Itaru Kojima.   

Abstract

The present study was conducted to establish a method to induce differentiation of bone marrow (MB)-derived mesenchymal cells into insulin-producing cells. When mouse BM-derived mesenchymal cells were cultured for 60 days in medium containing 10% fetal calf serum and 25 mM glucose, they expressed insulin. Addition of activin A and betacellulin (BTC) accelerated differentiation, and immunoreactive insulin was detected 14 days after the treatment. Insulin-containing secretory granules were observed in differentiated cells by electron microscopy. Treatment of BM-derived mesenchymal cells with conophylline (CnP) and BTC-delta4 further accelerated differentiation, and mRNA for insulin was detected 5 to 7 days after the treatment. Mesencymal cells treated with CnP and BTC-delta4 responded to a high concentration of glucose and secreted mature insulin. When these cells were transplanted into streptozotocin-treated mice, they markedly reduced the plasma glucose concentration, and the effect continued for at least 4 weeks. These results indicate an efficacy of the combination of CnP and BTC-delta4 in inducing differentiation of BM-derived mesenchymal cells into insulin-producing cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480554     DOI: 10.1507/endocrj.k07e-173

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  15 in total

Review 1.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 2.  Stem cell-derived islet cells for transplantation.

Authors:  Juan Domínguez-Bendala; Luca Inverardi; Camillo Ricordi
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

3.  Amniotic fluid stem cells prevent β-cell injury.

Authors:  Valentina Villani; Anna Milanesi; Sargis Sedrakyan; Stefano Da Sacco; Susanne Angelow; Maria Teresa Conconi; Rosa Di Liddo; Roger De Filippo; Laura Perin
Journal:  Cytotherapy       Date:  2013-11-07       Impact factor: 5.414

Review 4.  Mesenchymal stem cells in the treatment of pediatric diseases.

Authors:  Guo-Ping Zheng; Meng-Hua Ge; Qiang Shu; Mauricio Rojas; Jianguo Xu
Journal:  World J Pediatr       Date:  2013-08-09       Impact factor: 2.764

Review 5.  Screening of new bioactive metabolites for diabetes therapy.

Authors:  Kulrawee Sidthipong; Satoru Todo; Izumi Takei; Itaru Kojima; Kazuo Umezawa
Journal:  Intern Emerg Med       Date:  2013-04       Impact factor: 3.397

Review 6.  Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models.

Authors:  Kazuo Umezawa; Itaru Kojima; Siro Simizu; Yinzhi Lin; Hitomi Fukatsu; Naoki Koide; Yukiomi Nakade; Masashi Yoneda
Journal:  Hum Cell       Date:  2017-12-16       Impact factor: 4.174

7.  β-Cell Generation: Can Rodent Studies Be Translated to Humans?

Authors:  Françoise Carlotti; Arnaud Zaldumbide; Johanne H Ellenbroek; H Siebe Spijker; Rob C Hoeben; Eelco J de Koning
Journal:  J Transplant       Date:  2011-10-05

8.  Isolation and characterization of novel murine epiphysis derived mesenchymal stem cells.

Authors:  Chun-Chun Cheng; Wei-Shiung Lian; Felix Shih-Hsiang Hsiao; I-Hsuan Liu; Shau-Ping Lin; Yen-Hua Lee; Chia-Chun Chang; Guan-Yu Xiao; Hsin-Yi Huang; Ching-Feng Cheng; Winston Teng-Kuei Cheng; Shinn-Chih Wu
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Potential role of mesenchymal stem cells in alleviating intestinal ischemia/reperfusion impairment.

Authors:  Haitao Jiang; Linlin Qu; Rongrong Dou; Lianfang Lu; Sishan Bian; Weiming Zhu
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

10.  Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study.

Authors:  Yihua Zhang; Zhongying Dou
Journal:  Stem Cell Res Ther       Date:  2014-05-08       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.